Reply to: Caution is warranted in using cephamycin antibiotics against recurrent Clostridioides difficile infection
- 27 January 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Nature Microbiology
- Vol. 5 (2), 237-238
- https://doi.org/10.1038/s41564-019-0662-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Short- and long-term effects of oral vancomycin on the human intestinal microbiotaJournal of Antimicrobial Chemotherapy, 2016
- Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approachBMC Infectious Diseases, 2016
- Using combination therapy to thwart drug resistanceFuture Microbiology, 2015
- β-Lactam and glycopeptide antibiotics: first and last line of defense?Trends in Biotechnology, 2010
- The Changing Epidemiology of Clostridium difficile InfectionsClinical Microbiology Reviews, 2010
- Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 StrainGastroenterology, 2009
- Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile -Associated DiseaseAntimicrobial Agents and Chemotherapy, 2008
- Combination drugs, an emerging option for antibacterial therapyTrends in Biotechnology, 2007
- Emergence of Clostridium difficile-associated disease in North America and EuropeClinical Microbiology & Infection, 2006
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileThe New England Journal of Medicine, 2005